Henzen, D; Manser, P; Frei, D; Volken, W; Neuenschwander, H; Born, E J; Lössl, K; Aebersold, D M; Stampanoni, M F M; Fix, M K (2014). Forward treatment planning for modulated electron radiotherapy (MERT) employing Monte Carlo methods. Medical Physics, 41(3):031712.
Ghadjar, P; Sun, H; Zimmermann, F; Bodis, S; Bernier, J; Studer, G; Aebersold, D M (2013). Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94). Oral Oncology, 49(10):1006-1009.
Sassowsky, M; Gut, P; Hölscher, T; Hildebrandt, G; Müller, A C; Najafi, Y; Kohler, G; Kranzbühler, H; Guckenberger, M; Zwahlen, D R; Azinwi, N C; Plasswilm, L; Takacs, I; Reuter, C; Sumila, M; Manser, P; Ost, P; Böhmer, D; Pilop, C; Aebersold, D M; Ghadjar, P (2013). Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. International Journal of Radiation Oncology, Biology, Physics, 87(3):534-541.
Ghadjar, P; Blank-Liss, W; Simcock, M; Hegyi, I; Beer, K T; Moch, H; Aebersold, D M; Zimmer, Y (2009). MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clinical and Experimental Metastasis, 26(7):809-815.